Hers Plus
NDC 43742-1876, Calendula Officinalis, Sambucus Nigra, Allium Sativum, Clematis Erecta, Dulcamara, Sarsaparilla (Smilax Regelii), Graphites, Petroleum, Arsenicum Album, Croton Tiglium, Mercurius Sulphuratus Ruber, Natrum Muriaticum, Nitricum Acidum, Rhus Tox, Sepia, Thuja Occidentalis, liquid, from Deseret Biologicals,Inc..
- Product NDC
- 43742-1876
- Status
- Listed
- Labeler
- Deseret Biologicals,Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43742-1876 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CALENDULA OFFICINALIS FLOWERING TOP2 [hp_X]/mL
- SAMBUCUS NIGRA FLOWERING TOP3 [hp_X]/mL
- GARLIC6 [hp_X]/mL
- CLEMATIS RECTA FLOWERING TOP6 [hp_X]/mL
- SOLANUM DULCAMARA TOP6 [hp_X]/mL
- SMILAX ORNATA ROOT6 [hp_X]/mL
- GRAPHITE8 [hp_X]/mL
- KEROSENE8 [hp_X]/mL
- ARSENIC TRIOXIDE12 [hp_X]/mL
- CROTON TIGLIUM SEED12 [hp_X]/mL
- MERCURIC SULFIDE12 [hp_X]/mL
- SODIUM CHLORIDE12 [hp_X]/mL
- NITRIC ACID12 [hp_X]/mL
- TOXICODENDRON PUBESCENS LEAF12 [hp_X]/mL
- SEPIA OFFICINALIS JUICE12 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG12 [hp_X]/mL
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Plant Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43742-1876-1 | 43742187601 | 30 mL in 1 BOTTLE, DROPPER (43742-1876-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43742-1876 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43742-1876 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43742-1876. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.